ClinicalTrials.gg
Drug

Colchicine clinical trials

Also written Colcrys and Lodoco.

studies test it
239
open now
65
in phase 3
71
first study started
1990

How each study uses Colchicine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Colchicine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
27 Jul 1961 · COLBENEMID · NDA 012383 (FDA, Drugs@FDA; in a combination)
European Union
24 Jul 2026 · Colchicine Agepha Pharma · EMEA/H/C/006653 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Colchicine
138
Colchicine 0.5 MG
29
Colchicine Tablets
14
Colchicine 0.5 MG Oral Tablet
10
Colchicine 0.6 mg
9

Brand

Colcrys
33
Lodoco
5
Gloperba
3

Development codes

AR 374
1

Studies by the year they started

235 studies that test it; most in 2020 (26); 3 more planned to start later

Studies that test Colchicine, by start year
YearStudies
19901
20001
20021
20041
20054
20061
20078
200810
20094
20107
20112
20123
20139
201410
20154
20164
20176
20185
20198
202026
202124
202222
202316
202419
202519
202620

By phase

A phase 1/2 study counts in both.

Early Phase 1
5
Phase 1
34
Phase 2
71
Phase 3
71
Phase 4
51
No phase
22

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 27 · Other 212

Mutual Pharmaceutical Company, Inc. (19) · Population Health Research Institute (8) · Ain Shams University (5) · Montreal Heart Institute (5) · Assistance Publique - Hôpitaux de Paris (5) · NYU Langone Health (4) · Azienda Sanitaria Locale 3, Torino (4) · University of Sao Paulo General Hospital (3)

Often tested with

Tested in the same studies.

Rosuvastatin (4) · Aspirin (4) · Rivaroxaban (2) · Methotrexate (2) · Atorvastatin (2) · Febuxostat (2) · Naproxen (2) · Theophylline (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 23, 8 in phase 3

Studies that test Colchicine, phase 3 first.

Studies

Open first, then newest update. How each study uses Colchicine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 239

See all 239 studies that test Colchicine →

Given beside what is tested · 13 — Colchicine is usual care or a partner of the new treatment
As the comparator · 14 — what is tested is compared with Colchicine

Codes

What other systems call Colchicine · ClinicalTrials.gg INT007249

  • MeSH (NLM) D003078ColchicineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) SML2Y3J35TCOLCHICINEConfirmed FDA, NLM, Wikidata
  • RxNorm 2683Confirmed FDA, Wikidata
  • Wikidata Q326224(S)-(−)-colchicineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C385ColchicineOne source FDA
  • DrugBank DB01394One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.